Compound Monograph
Asparagamine A
Asparagamine A is a caged pentacyclic Stemona alkaloid, famous twice over — as a hard total-synthesis target solved by Overman in 2003, and as a textbook attribution error. It was described from shatavari in 1994, but authentic Asparagus racemosus does not contain it.
Sources · 5
Where Does It Come From?
Asparagamine A is a naturally occurring stemona alkaloid (pyrrolo[1,2-a]azepine, stemofoline/protostemonine type), found in Stemona collinsiae, Stemona curtisii and 3 other sources. It is flagged as moderately toxic.
Concentration
Content by Source
Reported concentrations across the plants that contain asparagamine A — the bar marks the typical level, the line shows the reported range.
Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.
Asparagamine A at a Glance
Asparagamine A is a caged pentacyclic alkaloid — C₂₂H₂₇NO₅, molecular weight 385.5 — built on the pyrrolo[1,2-a]azepine nucleus that defines the Stemona alkaloids, bridged into a rigid polycyclic cage and capped with a methoxy-methyl butenolide and a but-1-enyl side chain 1,
Two things make it worth a page, and neither is a health benefit.
First, the name is wrong. It was named for Asparagus racemosus — shatavari — because that is what the roots it came from were sold as. In 2004 Austrian workers showed the molecule is identical to 1’,2’-didehydrostemofoline from Stemona collinsiae 4Reference 4Two pyrrolo[1,2-a]azepine type alkaloids from Stemona collinsae Craib: structure elucidations, relationship to asparagamine A, and a new biogenetic concept of their formationView study →, and in 2013 Japanese regulators at the National Institute of Health Sciences analysed authenticated A. racemosus plants and commercial shatavari products and found no asparagamine A in any of them 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →. Shatavari does not make this molecule. Stemona does, and Stemona tubers look enough like shatavari root to be substituted for them.
Second, the structure was hard enough to be worth building. The cage attracted a decade of synthetic effort culminating in Overman’s 2003 total synthesis 15Reference 15Total synthesis of (±)-didehydrostemofoline (asparagamine A) and (±)-isodidehydrostemofolineView study →, with formal and core syntheses from Gin, Martin and Livinghouse either side of it 16,
The Shatavari Attribution Error
This is the single most important thing on the page, so it goes first.
1994 — the isolation. Sekine’s group at Chiba University, working with Nijsiri Ruangrungsi in Bangkok, isolated a new cage alkaloid from roots identified as Asparagus racemosus Willd. and named it asparagamine A 1Reference 1Structure of asparagamine A, a novel polycyclic alkaloid from Asparagus racemosusView study →. A companion 1995 paper in J. Chem. Soc. Perkin Trans. 1 reported its relative stereochemistry and, in its title, anti-oxytocin activity 2Reference 2Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosusView study →. Because shatavari’s headline traditional use is as a female reproductive tonic, an anti-oxytocic constituent was a satisfying result, and it entered the review literature immediately.
2004 — the structural identity. Seger, Greger and colleagues in Vienna solved X-ray structures for 2’-hydroxystemofoline and inferred the configuration of 1’,2’-didehydrostemofoline from Stemona collinsiae, and concluded that asparagamine A is the same compound. Their stated inference: the reported plant source of asparagamine A was most likely a Stemona species 4Reference 4Two pyrrolo[1,2-a]azepine type alkaloids from Stemona collinsae Craib: structure elucidations, relationship to asparagamine A, and a new biogenetic concept of their formationView study →.
2013 — the confirmation. Kumeta and colleagues at Japan’s National Institute of Health Sciences DNA-typed shatavari products on the Japanese market, confirmed by steroidal-saponin profiling that they really were Asparagus racemosus, then ran alkaloid analysis on both the products and an authentic A. racemosus plant. Neither contained asparagamine A. Their conclusion is unambiguous: A. racemosus does not contain it, and earlier isolations from material said to originate from A. racemosus were most likely misidentified Stemona 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →.
Why the mix-up is easy. Stemona species have clustered tuberous roots of very similar shape and colour to shatavari root, and they are traded in the same Southeast Asian markets. Pyrrolo[1,2-a]azepine alkaloids are, so far as anyone knows, exclusive to the Stemonaceae 8Reference 8Structural relationships, distribution and biological activities of Stemona alkaloidsView study → — so finding one in a lily-family root was always the anomaly, not the discovery.
The error is still propagating. A DPPH-guided antioxidant study from Chulalongkorn University in 2004 reports asparagamine A among the compounds isolated from A. racemosus roots 20Reference 20Identification of antioxidant compound from Asparagus racemosusView study → — the paper the original entry rested on. The NIH LactMed monograph for wild asparagus still lists “asparagamine” among shatavari’s constituents 21Reference 21In: Drugs and Lactation Database (LactMed) [Internet]View study →. A 2025 molecular-docking screen nominates asparagamine A as a lead antileishmanial from a library of Indian medicinal plant phytochemicals 22Reference 22Targeting spermidine synthase in Leishmania donovani: molecular docking and molecular dynamics simulation-based evaluation of Indian medicinal plant phytochemicalsView study →. None of these is dishonest; they are all downstream of a 1994 name that nobody re-checked.
What therefore cannot be said. It does not treat asparagamine A as a shatavari constituent, does not carry its “antioxidant” reputation forward, and does not use it to explain anything about how shatavari works. Shatavari’s pharmacology rests on its steroidal saponins — the shatavarins, built on the sarsasapogenin aglycone — plus its fructo-oligosaccharides and phenolics, none of which are affected by this correction.
What It's Used For
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every score here is capped low: there are no human data of any kind, and the total PubMed literature under the name asparagamine is ten records. Each application links to its write-up.
This is the molecule’s real pharmacology, and it is good work. A 2001 Thai study first reported 16,17-didehydro-16(E)-stemofoline from Stemona collinsae and found it more insecticidal and more antifeedant against diamondback moth larvae than stemofoline itself 5Reference 5Occurrence of the insecticidal 16,17-didehydro-16(E)-stemofoline in Stemona collinsaeView study →.
A 2002 Vienna study put numbers on it: methanolic root and leaf extracts of S. collinsae were far more toxic to neonate Spodoptera littoralis larvae than two Aglaia species, a commercial pyrethrum extract or azadirachtin, and the activity tracked the pyrrolo[1,2-a]azepine alkaloids — with didehydrostemofoline the major root compound and the most toxic in feeding assays. In contact-toxicity tests, stemofoline and didehydrostemofoline exceeded pyrethrum 6Reference 6Feeding deterrence and contact toxicity of Stemona alkaloids — a source of potent natural insecticidesView study →.
Saturating or hydroxylating the side chain progressively destroyed the activity, which is a clean structure–activity result for a natural product 6Reference 6Feeding deterrence and contact toxicity of Stemona alkaloids — a source of potent natural insecticidesView study →.
Greger’s 2006 review of 82 Stemona alkaloids reaches the same conclusion across the genus: roots dominated by protostemonine-type derivatives, especially didehydrostemofoline, show very high insect toxicity, while species dominated by tuberostemonine are merely repellent 8Reference 8Structural relationships, distribution and biological activities of Stemona alkaloidsView study →. Against mosquito larvae the isolated compound gives LC₅₀ 2.44 µM for Aedes aegypti — the most active compound in that screen 11Reference 11Cytotoxic and larvicidal activities of Stemona alkaloids from the aerial parts and roots of Stemona curtisii Hook.fView study →.
The commercial epilogue. Bayer’s flupyradifurone, the first member of the butenolide insecticide class, was discovered from a design programme “inspired by the butenolide scaffold in naturally occurring stemofoline” and acts as a reversible agonist at insect nicotinic acetylcholine receptors 23Reference 23Flupyradifurone: a brief profile of a new butenolide insecticideView study →. That is stemofoline, not didehydrostemofoline — but it is the same butenolide pharmacophore on the same cage, and it is the clearest evidence that this scaffold does something real at an insect receptor.
Gap: the target has not been confirmed for asparagamine A itself. No published binding or electrophysiology assigns it to the insect nAChR; the receptor attribution is inherited from the flupyradifurone programme and from the class 23Reference 23Flupyradifurone: a brief profile of a new butenolide insecticideView study →. Everything here is invertebrate toxicology, which says nothing about human pharmacology in either direction.
Stemona roots are a traditional anthelmintic and pesticide across Southeast Asia 24Reference 24ReviewThe traditional uses, phytochemistry, and pharmacology of Stemona species: a reviewView study →, and a Mahidol University group has pursued that for human gnathostomiasis — a parasitic infection with few good drugs. A 2024 study standardised an ethanolic S. collinsiae root extract using didehydrostemofoline as the chemical marker and tested it against advanced third-stage Gnathostoma spinigerum larvae in vitro and in infected Wistar rats. The extract produced clear morphological damage to larvae in vitro, reduced larval burden in vivo, and provoked less inflammatory reaction than albendazole; acute toxicity in rats gave a GHS LD₅₀ around 500 mg/kg, with 300 mg/kg non-toxic and 2,000 mg/kg fatal 13Reference 13Assessing the efficacy of Stemona collinsiae roots extract against third-stage larvae of Gnathostoma spinigerum and its safety profilesView study →.
Gap: and here is the honest limit — this is an extract result, not a molecule result. Asparagamine A is the marker used to standardise the preparation, not the tested agent, and the extract contains stemofoline and other alkaloids. No isolate has been run against a helminth. The activity may well be the marker compound; nothing published demonstrates that it is 13Reference 13Assessing the efficacy of Stemona collinsiae roots extract against third-stage larvae of Gnathostoma spinigerum and its safety profilesView study →.
The one piece of mammalian cell pharmacology worth taking seriously. A 2017 Chiang Mai / Wollongong collaboration screened eight Stemona alkaloids for multidrug-resistance reversal in K562/Adr human leukaemia cells, which overexpress P-glycoprotein. Three were active — isostemofoline and both geometric isomers, 11Z-didehydrostemofoline and 11E-didehydrostemofoline. All three increased intracellular accumulation of the P-gp substrates calcein-AM and rhodamine-123 in the resistant line but not in the drug-sensitive parental K562 line, and Western blot showed no change in P-gp expression — so the mechanism is functional inhibition of the transporter, not downregulation 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
The safety controls in that paper are better than usual for this genre: the active alkaloids were not cytotoxic to normal human fibroblasts or peripheral blood mononuclear cells, and did not haemolyse human or rat erythrocytes 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
Gap: one study, one resistant cell line, no potency figure carried into an animal, and no follow-up in the nine years since. P-gp inhibition is also a drug-interaction mechanism before it is a therapy — anything that blocks P-gp raises exposure to the many drugs it exports. Related work on semisynthetic stemofoline derivatives points the same way 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
The 1995 paper in Journal of the Chemical Society, Perkin Transactions 1 is titled “Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosus” 2Reference 2Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosusView study →. That title is the whole of the primary record that is readily reachable: the paper is a structural report with an activity note, not a pharmacology study, and it has never been replicated by any group.
Three problems compound each other. The source attribution in that very title is wrong 3,
Gap: no dose–response, no receptor work, no animal model, no replication. Treat this as a historical footnote, not a mechanism 2Reference 2Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosusView study →.
This entry exists to retire a claim rather than support one. The 2004 Phytotherapy Research paper routinely cited for “asparagamine A is an antioxidant” used DPPH-autography-directed separation of Asparagus racemosus roots and identified a new antioxidant compound, racemofuran, “along with two known compounds asparagamine A and racemosol” 20Reference 20Identification of antioxidant compound from Asparagus racemosusView study →.
The only antioxidant potency reported is racemofuran’s DPPH IC₅₀ of 130 µM. No IC₅₀, no ORAC value, no cellular assay and no comparison is published for asparagamine A.
So the claim reduces to: a compound was co-isolated during a fractionation that was guided by an antioxidant stain. And the plant it was isolated from is the plant that, on the best available analysis, does not contain it 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →.
Gap: everything. There is no quantitative antioxidant measurement of asparagamine A in the literature, and structurally there is no reason to expect one — the molecule has no phenol, no catechol and no obvious redox-active handle 20Reference 20Identification of antioxidant compound from Asparagus racemosusView study →.
Mechanisms
| Target / pathway | Effect | Relevant to | Species |
|---|---|---|---|
| Insect feeding & survival (Spodoptera, diamondback moth) | Antifeedant + contact toxicity exceeding pyrethrum extract | insecticidal | invertebrate |
| Mosquito larvae (Aedes aegypti) | LC₅₀ 2.44 µM | larvicidal | invertebrate |
| Nematode larvae (Gnathostoma spinigerum) | Morphological damage + reduced burden — extract, marker compound only | anthelmintic | rat / in vitro |
| P-glycoprotein (ABCB1) | Functional inhibition; ↑ calcein-AM and rhodamine-123 accumulation in K562/Adr, no change in P-gp expression | MDR reversaldrug interactions | human cell line |
| Insect nicotinic acetylcholine receptor | Inferred for the scaffold via flupyradifurone; not demonstrated for this molecule | insecticidal | — |
| Oxytocin response | ”Anti-oxytocin activity”, 1995, unreplicated | uterine tone (historical) | — |
Pharmacokinetics
Unusually for a molecule this obscure, real pharmacokinetics exist. A 2024 Mahidol study developed and validated an LC-MS/MS assay for didehydrostemofoline in rat plasma and applied it after oral administration of standardised S. collinsiae root extract 14Reference 14AnimalLC-MS/MS analysis of didehydrostemofoline from Stemona collinsiae roots extracts in rats plasma and pharmacokinetics profile after oral administrationView study →:
| Parameter | Value (rat, oral extract) |
|---|---|
| Tmax | 1.75 ± 0.62 h |
| Cmax | 1,152.58 ± 271.18 ng/mL |
| Terminal half-life | 1.86 ± 0.50 h |
| Apparent clearance | 96.82 ± 23.51 L/h |
| Apparent volume of distribution | 260.40 ± 96.81 L |
The interpretable findings are the first three: it is rapidly absorbed from the gastrointestinal tract and rapidly eliminated, with a sub-two-hour half-life. The clearance and volume figures are reported without body-weight normalisation and without the administered dose in the abstract, so they should not be read as rat-specific constants.
This is a real contrast with the large glycosides and tannins that dominate the herbal literature: at 385 Da, lipophilic and un-glycosylated, asparagamine A does reach plasma. Whether it reaches any target of human relevance once there is entirely unstudied.
Clinical Trials
None. There is no clinical trial of asparagamine A under any of its names, and no registered study. Human exposure is limited to whatever occurs when Stemona root is used traditionally, or when Stemona material is substituted for shatavari in commerce — which is exactly the substitution the 2013 analysis was designed to detect 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| —(none) | — | — | In-vitro + rodent only |
Last checked: August 2026.
Isolate vs. Plant
The isolate/plant line is drawn in an unusual place here, because the plant most people associate with the molecule is the wrong plant.
Where the isolate did the work: the insecticidal structure–activity comparisons 5,
Where the extract did the work: the anthelmintic and toxicity results, in which asparagamine A serves only as the HPLC marker used to standardise the preparation 13,
Where neither did the work: every claim that runs from this molecule to shatavari. There is no transfer to make, because there is no molecule in the plant 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →.
Prevalence in Nature
Pyrrolo[1,2-a]azepine alkaloids of this type are, on current evidence, restricted to the family Stemonaceae — three genera, mostly Southeast Asian 8Reference 8Structural relationships, distribution and biological activities of Stemona alkaloidsView study →. Within that family, accumulation is strikingly species-specific, which is why these alkaloids work as chemotaxonomic markers.
| Source | Part | Basis |
|---|---|---|
| Stemona collinsiae (syn. S. collinsae) | Roots | The true source and the richest — didehydrostemofoline is its species-specific chemical marker 7, |
| Stemona curtisii | Aerial parts | (11Z)-1’,2’-Didehydrostemofoline isolated alongside stemocurtisine and related alkaloids 11Reference 11Cytotoxic and larvicidal activities of Stemona alkaloids from the aerial parts and roots of Stemona curtisii Hook.fView study → |
| Stemona aphylla | Roots | Stemofoline-type alkaloids including didehydrostemofoline in the accumulation profile 10Reference 10Structural relationships of Stemona alkaloids: assessment of species-specific accumulation trends for exploiting their biological activitiesView study → |
| Asparagus racemosus (shatavari) | Root | Not present. Authenticated plant material and market products both tested negative 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study → |
A 2007 survey of 31 Stemona species and provenances found the unique accumulation of didehydrostemofoline to be the chemical signature of S. collinsae specifically 7Reference 7Pyrrolo- and pyridoazepine alkaloids as chemical markers in Stemona speciesView study →, and a 2011 comparison across 42 samples of eight species confirmed that S. curtisii and S. collinsiae are the stemofoline/didehydrostemofoline accumulators while S. tuberosa and S. phyllantha run to tuberostemonine instead 10Reference 10Structural relationships of Stemona alkaloids: assessment of species-specific accumulation trends for exploiting their biological activitiesView study →. The practical consequence is that “Stemona extract” is not one thing — the alkaloid profile, and therefore the insecticidal potency, depends entirely on which species was collected.
Discovery & Synthesis
This is the section with the most in it, because the synthetic-chemistry story is genuinely larger than the pharmacology.
Isolation & Structure
1994. Toshikazu Sekine, Nobuaki Fukasawa, Yumi Kashiwagi, Nijsiri Ruangrungsi and Isamu Murakoshi reported a new cage-type alkaloid from roots identified as Asparagus racemosus Willd., naming it asparagamine A. The relative stereostructure was settled by spectroscopic, chemical and single-crystal X-ray analysis, and described as a novel polycyclic pyrrolizidine derivative 1Reference 1Structure of asparagamine A, a novel polycyclic alkaloid from Asparagus racemosusView study →. 1995. A fuller account in J. Chem. Soc. Perkin Trans. 1 gave the relative stereochemistry and reported anti-oxytocin activity 2Reference 2Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosusView study →. 2001. Independently, a Thai–Japanese group reported the same skeleton as 16,17-didehydro-16(E)-stemofoline from Stemona collinsae, together with its C-4 isomer and stemofoline, and noted it was the more insecticidal of the pair 5Reference 5Occurrence of the insecticidal 16,17-didehydro-16(E)-stemofoline in Stemona collinsaeView study →. 2004. Seger, Mereiter, Kaltenegger, Pacher, Greger and Hofer closed the loop: X-ray and NMR comparison established that asparagamine A is 1’,2’-didehydrostemofoline, and that the reported source was most likely a Stemona 4Reference 4Two pyrrolo[1,2-a]azepine type alkaloids from Stemona collinsae Craib: structure elucidations, relationship to asparagamine A, and a new biogenetic concept of their formationView study →. 2013. Kumeta and colleagues confirmed the absence from authentic A. racemosus 3Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →.
The molecule is registered as PubChem CID 56666692, ChEBI:70413, C₂₂H₂₇NO₅, MW 385.5 — under the name didehydrostemofoline, with asparagamine A surviving only as a synonym.
Why It Became a Synthesis Target
The appeal is structural, not medicinal. The core is a pentacyclic cage containing a bridged azabicyclic system, two oxygen-containing rings, seven contiguous stereocentres, an anhydride-free but highly oxygenated architecture, and a stereodefined exocyclic butenolide with a pendant but-1-enyl chain whose geometry distinguishes the natural product from its “iso” congener. Building a strained bridged cage while controlling that many centres — and then installing the alkene geometry last — is a genuinely hard problem, which is why it drew four separate research programmes.
| Year | Group | Achievement | Ref |
|---|---|---|---|
| 2002 | Epperson & Gin (Illinois) | Enantiospecific synthesis of the bridged pyrrolizidine core, via dipolar cycloaddition of azomethine ylides from sulfonylation of vinylogous amides | 16Reference 16Enantiospecific synthesis of the bridged pyrrolizidine core of asparagamine A: dipolar cycloadditions of azomethine ylides derived from the sulfonylation of vinylogous amidesView study → |
| 2003 | Brüggemann, McDonald, Overman, Rosen, Schwink & Scott (UC Irvine) | First total synthesis of (±)-didehydrostemofoline (asparagamine A) and (±)-isodidehydrostemofoline | 15Reference 15Total synthesis of (±)-didehydrostemofoline (asparagamine A) and (±)-isodidehydrostemofolineView study → |
| 2012 | Fang, Shanahan, Paull & Martin (UT Austin) | Enantioselective formal total syntheses of both isomers, 24 steps from 2-deoxy-D-ribose | 17Reference 17Enantioselective formal total syntheses of didehydrostemofoline and isodidehydrostemofoline through a catalytic dipolar cycloaddition cascadeView study → |
| 2013 | Shanahan, Fang, Paull & Martin (UT Austin) | Full account of the catalytic dipolar-cycloaddition cascade, intercepting an Overman intermediate | 18Reference 18Asymmetric formal total synthesis of the stemofoline alkaloids: the evolution, development and application of a catalytic dipolar cycloaddition cascadeView study → |
| 2015 | Anderson & Livinghouse (Montana State) | Divergent stereocontrolled synthesis of the enantiopure tetracyclic cores of asparagamine A and stemofoline | 19Reference 19Divergent stereocontrolled synthesis of the enantiopure tetracyclic cores of asparagamine A and stemofoline via an intramolecular 2-propylidine-1,3-(bis)silane bicyclizationView study → |
Overman’s route (2003) opens with a Diels–Alder reaction between a pyrrole and ethyl (E)-3-nitroacrylate — the nitroacrylate acting as a regio-inverted ketene equivalent — then hydrogenates the adduct to block retro-Diels–Alder, converts it to a 7-azabicyclo[2.2.1]heptanol, and uses an aza-Cope–Mannich reaction on the formaldiminium derivative to deliver the 1-azatricyclo[5.3.0.0⁴,¹⁰]decane. Fifteen further steps give both natural products 15Reference 15Total synthesis of (±)-didehydrostemofoline (asparagamine A) and (±)-isodidehydrostemofolineView study →. It is a textbook demonstration of the aza-Cope–Mannich rearrangement Overman is known for.
Martin’s route (2012–13) approaches the same tricyclic core through a rhodium carbene that cyclises onto a proximal imine nitrogen to generate an azomethine ylide, which then undergoes spontaneous intramolecular dipolar cycloaddition — the whole core assembled from an acyclic precursor in a single cascade operation 17,
From Cage Alkaloid to Crop Protection
The most consequential downstream product of this chemistry is not a drug. Bayer’s flupyradifurone, launched as the first butenolide insecticide, came out of a discovery programme built around the butenolide scaffold of stemofoline; it acts reversibly as an agonist at insect nicotinic acetylcholine receptors, is structurally distinct from the neonicotinoids, and is not metabolised by CYP6CM1, the P450 behind metabolic neonicotinoid resistance in whiteflies 23Reference 23Flupyradifurone: a brief profile of a new butenolide insecticideView study →. The natural product that put that scaffold on the map — and the more toxic of the pair in every side-by-side insect assay 5,
There is no commercial preparation of asparagamine A. All material used in biology has come from Stemona root chromatography; all synthetic material has come from academic total or formal syntheses. Patents: not yet researched.
Toxicity & Safety
The honest verdict is not characterised in humans, and not a dietary molecule. The moderate grading reflects what it demonstrably is — a potent invertebrate neurotoxin from a pesticidal plant, with no mammalian isolate toxicology — rather than any demonstrated human harm.
- No human adverse effect has been reported. No human has knowingly taken it, so this is an absence of data, not a safety record.
- Not cytotoxic to normal human cells in the one test available. Neither isomer harmed normal fibroblasts or peripheral blood mononuclear cells, and neither haemolysed human or rat erythrocytes 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
- It is a potent insecticide, more toxic to insects than pyrethrum in contact assays 6Reference 6Feeding deterrence and contact toxicity of Stemona alkaloids — a source of potent natural insecticidesView study →. Selectivity for invertebrates is likely but has never been formally established for this molecule.
- Orally bioavailable in rats. Unlike most large plant molecules it does reach plasma quickly 14Reference 14AnimalLC-MS/MS analysis of didehydrostemofoline from Stemona collinsiae roots extracts in rats plasma and pharmacokinetics profile after oral administrationView study →, so an isolate exposure would be a real systemic exposure.
- P-glycoprotein inhibition is a drug-interaction mechanism. Functional P-gp blockade raises exposure to the many drugs that transporter exports 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
- The extract’s rodent LD₅₀ is around 500 mg/kg. For standardised S. collinsiae root extract, 300 mg/kg was non-toxic and 2,000 mg/kg was fatal in Wistar rats 13Reference 13Assessing the efficacy of Stemona collinsiae roots extract against third-stage larvae of Gnathostoma spinigerum and its safety profilesView study → — an extract figure, not an isolate figure.
- No reproductive or developmental data exist. The one reproductive-sounding result in the whole literature is the unreplicated 1995 anti-oxytocin note 2Reference 2Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosusView study →, which is not a safety finding in either direction.
- Product substitution is the real-world risk. Stemona tubers have been sold as shatavari 3,
4Reference 3Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosusView study →Reference 4Two pyrrolo[1,2-a]azepine type alkaloids from Stemona collinsae Craib: structure elucidations, relationship to asparagamine A, and a new biogenetic concept of their formationView study → — the practical hazard is buying the wrong plant, not this molecule’s own toxicity.
Full Safety & Interactions Detail
No toxicology study has ever been performed on isolated asparagamine A in a mammal. What exists is bracketed on one side by invertebrate data — high contact and feeding toxicity to lepidopteran larvae, exceeding a commercial pyrethrum extract 6Reference 6Feeding deterrence and contact toxicity of Stemona alkaloids — a source of potent natural insecticidesView study →, and an Aedes larval LC₅₀ of 2.44 µM 11Reference 11Cytotoxic and larvicidal activities of Stemona alkaloids from the aerial parts and roots of Stemona curtisii Hook.fView study → — and on the other by a single mammalian-cell safety panel in which neither geometric isomer was cytotoxic to normal human fibroblasts or PBMCs and neither caused haemolysis 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →. Between those two poles there is nothing: no acute oral study of the isolate, no genotoxicity, no repeat-dose work, no reproductive study.
The extract-level toxicity data give a rough outer bound. In Wistar rats, standardised ethanolic S. collinsiae root extract was fatal at 2,000 mg/kg, non-toxic at 300 mg/kg, and assigned a GHS LD₅₀ of 500 mg/kg 13Reference 13Assessing the efficacy of Stemona collinsiae roots extract against third-stage larvae of Gnathostoma spinigerum and its safety profilesView study → — but that extract is a mixture, and the contribution of any single alkaloid to that figure is unknown.
The interaction to take seriously is P-glycoprotein. Both isomers inhibit P-gp function in resistant leukaemia cells without changing its expression 12Reference 12Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationshipsView study →.
P-gp governs the absorption and biliary/renal export of a long list of drugs — digoxin, many kinase inhibitors, several immunosuppressants, some anticoagulants and antiretrovirals — so functional inhibition is a plausible route to raised drug levels. Nothing here has been tested in vivo, and this concerns the isolate rather than any product a person would encounter.
Finally, the safety question most likely to matter in practice is botanical identity. The reason this molecule was ever associated with a women’s tonic is that Stemona root has been substituted for shatavari in trade 3,
Dosage
There is no dose. Asparagamine A has never been given to a human as an isolate or a defined preparation, and there is no rationale on which to construct one. Every quantitative figure in this article is an insect LC₅₀, a cell-line accumulation assay, a rat plasma concentration, or an extract LD₅₀.
Where it appears in the real world it does so as a standardisation marker for Stemona collinsiae root extract in pesticide and anthelmintic development 9,
References
- Sekine T, Fukasawa N, Kashiwagi Y, Ruangrungsi N, Murakoshi I (1994). Structure of asparagamine A, a novel polycyclic alkaloid from Asparagus racemosus. Chemical and Pharmaceutical Bulletin 42(6):1360–1362. https://doi.org/10.1248/cpb.42.1360
- Sekine T, Ikegami F, Fukasawa N, Kashiwagi Y, Aizawa T, Fujii Y, Ruangrungsi N, Murakoshi I (1995). Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosus. Journal of the Chemical Society, Perkin Transactions 1 391–393. https://doi.org/10.1039/p19950000391
- Kumeta Y, Maruyama T, Wakana D, Kamakura H, Goda Y (2013). Chemical analysis reveals the botanical origin of shatavari products and confirms the absence of alkaloid asparagamine A in Asparagus racemosus. Journal of Natural Medicines. https://pubmed.ncbi.nlm.nih.gov/22529051/
- Seger C, Mereiter K, Kaltenegger E, Pacher T, Greger H, Hofer O (2004). Two pyrrolo[1,2-a]azepine type alkaloids from Stemona collinsae Craib: structure elucidations, relationship to asparagamine A, and a new biogenetic concept of their formation. Chemistry & Biodiversity. https://pubmed.ncbi.nlm.nih.gov/17191845/
- Jiwajinda S, Hirai N, Watanabe K, Santisopasri V, Chuengsamarnyart N, Koshimizu K, Ohigashi H (2001). Occurrence of the insecticidal 16,17-didehydro-16(E)-stemofoline in Stemona collinsae. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/11314954/
- Brem B, Seger C, Pacher T, Hofer O, Vajrodaya S, Greger H (2002). Feeding deterrence and contact toxicity of Stemona alkaloids — a source of potent natural insecticides. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/12381121/
- Schinnerl J, Brem B, But PP, Vajrodaya S, Hofer O, Greger H (2007). Pyrrolo- and pyridoazepine alkaloids as chemical markers in Stemona species. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/17449078/
- Greger H (2006). Structural relationships, distribution and biological activities of Stemona alkaloids. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/16491444/
- Kongkiatpaiboon S, Gritsanapan W (2012). HPLC quantitative analysis of insecticidal didehydrostemofoline and stemofoline in Stemona collinsiae root extracts. Phytochemical Analysis. https://pubmed.ncbi.nlm.nih.gov/22396063/
- Kongkiatpaiboon S, Schinnerl J, Felsinger S, Keeratinijakal V, Vajrodaya S, Gritsanapan W, Brecker L, Greger H (2011). Structural relationships of Stemona alkaloids: assessment of species-specific accumulation trends for exploiting their biological activities. Journal of Natural Products. https://pubmed.ncbi.nlm.nih.gov/21902195/
- Chalom S, Panyakaew J, Phaya M, Pyne SG, Mungkornasawakul P (2021). Cytotoxic and larvicidal activities of Stemona alkaloids from the aerial parts and roots of Stemona curtisii Hook.f. Natural Product Research. https://pubmed.ncbi.nlm.nih.gov/31899956/
- Umsumarng S, Pitchakarn P, Yodkeeree S, Punfa W, Mapoung S, Ramli RA, Pyne SG, Limtrakul P (2017). Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/28899501/
- Arlee N, Ampawong S, Kongkiatpaiboon S, Limpanont Y, Arunrungvichian K, Thepouyporn A, Pakdee W, Thaenkham U (2024). Assessing the efficacy of Stemona collinsiae roots extract against third-stage larvae of Gnathostoma spinigerum and its safety profiles. Heliyon. https://pubmed.ncbi.nlm.nih.gov/39397923/
- Arlee N, Ampawong S, Limpanont Y, Arunrungvichian K, Kongkiatpaiboon S, Thaenkham U (2024). LC-MS/MS analysis of didehydrostemofoline from Stemona collinsiae roots extracts in rats plasma and pharmacokinetics profile after oral administration. Fitoterapia. https://pubmed.ncbi.nlm.nih.gov/38823598/
- Brüggemann M, McDonald AI, Overman LE, Rosen MD, Schwink L, Scott JP (2003). Total synthesis of (±)-didehydrostemofoline (asparagamine A) and (±)-isodidehydrostemofoline. Journal of the American Chemical Society 125(50):15284–15285. https://pubmed.ncbi.nlm.nih.gov/14664560/
- Epperson MT, Gin DY (2002). Enantiospecific synthesis of the bridged pyrrolizidine core of asparagamine A: dipolar cycloadditions of azomethine ylides derived from the sulfonylation of vinylogous amides. Angewandte Chemie International Edition. https://pubmed.ncbi.nlm.nih.gov/19750714/
- Fang C, Shanahan CS, Paull DH, Martin SF (2012). Enantioselective formal total syntheses of didehydrostemofoline and isodidehydrostemofoline through a catalytic dipolar cycloaddition cascade. Angewandte Chemie International Edition. https://pubmed.ncbi.nlm.nih.gov/22987285/
- Shanahan CS, Fang C, Paull DH, Martin SF (2013). Asymmetric formal total synthesis of the stemofoline alkaloids: the evolution, development and application of a catalytic dipolar cycloaddition cascade. Tetrahedron. https://pubmed.ncbi.nlm.nih.gov/24072939/
- Anderson BK, Livinghouse T (2015). Divergent stereocontrolled synthesis of the enantiopure tetracyclic cores of asparagamine A and stemofoline via an intramolecular 2-propylidine-1,3-(bis)silane bicyclization. The Journal of Organic Chemistry. https://pubmed.ncbi.nlm.nih.gov/26360508/
- Wiboonpun N, Phuwapraisirisan P, Tip-pyang S (2004). Identification of antioxidant compound from Asparagus racemosus. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/15478181/
- Wild Asparagus. In: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006 (record updated July 2026). https://pubmed.ncbi.nlm.nih.gov/30000872/
- Arya PK, Barik K, Kumar A (2026). Targeting spermidine synthase in Leishmania donovani: molecular docking and molecular dynamics simulation-based evaluation of Indian medicinal plant phytochemicals. In Silico Pharmacology. https://pubmed.ncbi.nlm.nih.gov/41459411/
- Nauen R, Jeschke P, Velten R, Beck ME, Ebbinghaus-Kintscher U, Thielert W, Wölfel K, Haas M, Kunz K, Raupach G (2015). Flupyradifurone: a brief profile of a new butenolide insecticide. Pest Management Science. https://pubmed.ncbi.nlm.nih.gov/25351824/
- Liu Y, Shen Y, Teng L, Yang L, Cao K, Fu Q, Zhang J (2021). The traditional uses, phytochemistry, and pharmacology of Stemona species: a review. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/32726680/
- Sastraruji K, Sastraruji T, Pyne SG, Ung AT, Jatisatienr A, Lie W (2010). Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline alkaloids and analogues. Journal of Natural Products. https://pubmed.ncbi.nlm.nih.gov/20415428/
